We thank the European Organization for Research and Treatment of Cancer (EORTC) Headquarters, EORTC Clinical Groups, and all of the principal investigators (W. Albrecht, J. Becker, R. E. Coleman, T. Conroy, R. de Wit, A. Eggermont, S. Fossa, G. Giaccone, J. C. Horiot, F. Keuppens, C. H. Koehne, J. L. Lefebvre, F. Levi, G. O. N. Oosterhof, M. Piccart, P. Postmus, H. J. Schmoll, E. F. Smit, T. A. W. Splinter, M. J. Taphoorn, P. Therasse, J. Van Meerbeeck, and H. Van Poppel) who helped us better understand the needs of cancer patients, which will ultimately lead to better patient care. We also extend a warm thanks to Cheryl Whittaker for proofreading the article. We give very special thanks to all of the patients who participated in these trials.
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites
Article first published online: 11 OCT 2013
© 2013 American Cancer Society
Volume 120, Issue 2, pages 302–311, 15 January 2014
How to Cite
Quinten, C., Martinelli, F., Coens, C., Sprangers, M. A. G., Ringash, J., Gotay, C., Bjordal, K., Greimel, E., Reeve, B. B., Maringwa, J., Ediebah, D. E., Zikos, E., King, M. T., Osoba, D., Taphoorn, M. J., Flechtner, H., Schmucker-Von Koch, J., Weis, J., Bottomley, A. and on behalf of Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer (EORTC) Clinical Groups (2014), A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer, 120: 302–311. doi: 10.1002/cncr.28382
The sponsors had no role in the design of the study; the collection, analysis, or interpretation of the data; the writing of the article; or the decision to submit the article for publication.
- Issue published online: 7 JAN 2014
- Article first published online: 11 OCT 2013
- Manuscript Accepted: 2 AUG 2013
- Manuscript Revised: 4 JUL 2013
- Manuscript Received: 27 FEB 2013
- 6Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. J Clin Oncol. 2009;27:2916-2923., , , et al.
- 9US Food and Drug Administration. Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labelling Claims. Rockville, MD: US Food and Drug Administration; 2006.
- 13A patient-level meta-analytic investigation of the prognostic significance of baseline quality of life (QOL) for overall survival (OS) among 3,704 patients participating in 24 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials [abstract]. J Clin Oncol. 2007;26(suppl). Abstract 9515., , , et al.
- 15Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation. Expert Rev Pharmacoecon Outcomes Res. 2008;8:179-196., , , .
- 18Groenveld M. EORTC QLQ-C30 Scoring Manual. 2nd ed. Brussels, Belgium: EORTC Quality of Life Study Group; 2001., , , .
- 25Regression models and life tables. J R Stat Soc. 1972;34:187-220..
- 26Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian Lung Cancer in the Elderly study. J Clin Oncol. 2005;23:6865-6872., , , et al.
- 39The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncoiogy Groups, and NCIC Clinical Trials Group study. Br J Cancer. 2007;97:302-307., , , et al.
- 49National Cancer Institute. Patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Available from http://outcomes.cancer.gov/tools/pro-ctcae.html. Assessed September 18, 2013.